RAD9A and neoplasm: To test our hypothesis that alterations in tumor-relevant genes may be associated with changes in RAD9A methylation, we performed an SNP array analysis of hypermethylated (4, 6 and 10) and hypomethylated (2 and 9) FaDu subclones.